Adagrasib: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

25 April 2024

31 January 2024

  • curprev 20:3020:30, 31 January 2024‎ Alara E. Dagsali talk contribs‎ 28,883 bytes +28,883‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E. Dagsali |genericName=adagrasib |aOrAn=an |indicationType=treatment |indication=KRAZATI is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test [see DOSAGE AND ADMINISTRATION (2.1)], who have received at least one prior systemic therapy. This indication is approved under accelerated approval based on ob..."
Retrieved from "https://www.wikidoc.org/index.php/Adagrasib"